Company: LHI
Filing Date: 2025-05-23
Form Type: F-1
Source: 0001213900-25-046955
Chunk: 10

Company: Living Homeopathy International Ltd.
Filing Date: 2025-05-23
Form: F-1
Chunk 10
---
 Public offering price(1)           |     | $         | 5.0 |     | $     | 6,250,000 |
| Underwriter discounts(2)           |     | $         | 0.3 |     | $     |   375,000 |
| Proceeds to us, before expenses(3) |     | $         | 4.7 |     | $     | 5,875,000 |

| (1) | Initial                                                                                                                                  
 public offering price per share is assumed at $5.0 per Class A Ordinary Share, which is the midpoint of the estimated initial public     
 offering price range set forth on the cover page of this prospectus. The table above assumes that the underwriters do not exercise their 
 over-allotment option. For more information, see “Underwriting” beginning on page 130 of this prospectus.                                |

| (2) | An underwriting                                                                       
 discount equal to 6.0% of the public offering price will be provided to underwriters. |

| (3) | Living Homeopathy expects                                                                                                          
 its cash expenses for this offering (including cash expenses payable to its underwriter for the underwriter’s out-of-pocket        
 expenses) not to exceed $[●]. For a detailed description of the compensation to be received by the underwriter, see “Underwriting” 
 beginning on page 130 of this prospectus.                                                                                          |

This offering is being conducted
on a firm commitment basis. The underwriter is obligated to take and pay for all of the Class A Ordinary Shares if any such Class A Ordinary
Shares are taken. Assuming an offering price of $5.0 per Ordinary Share, which is the midpoint of the estimated initial public offering
range set forth on the cover page of this prospectus, the total gross proceeds to Living Homeopathy, before underwriting discounts and
expenses, will be $6,250,000.

We have granted the underwriters an option, exercisable for 45 days after
the closing date of this offering, to purchase up to an additional 15% of the Class A Ordinary Shares offered in this offering on the
same terms to cover over-allotments, if any.

The underwriter expects
to deliver the Class A Ordinary Shares to purchasers in the offering on or about [●], 2025.

Living Homeopathy may amend or supplement this prospectus from time to time by filing amendments or supplements as required. You should read this entire prospectus and any